Literature DB >> 27185851

Antimetastatic Properties of Low Molecular Weight Heparin.

Heinz Läubli1, Ajit Varki2, Lubor Borsig3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27185851     DOI： 10.1200/JCO.2016.66.4607

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

Review 2.  New Applications of Heparin and Other Glycosaminoglycans.

Authors:  Marcelo Lima; Timothy Rudd; Edwin Yates
Journal:  Molecules       Date:  2017-05-06       Impact factor: 4.411

3.  Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.

Authors:  Rebecca C Auer; Michael Ott; Paul Karanicolas; Muriel Rebecca Brackstone; Shady Ashamalla; Joel Weaver; Vicky Tagalakis; Marylise Boutros; Peter Stotland; Antonio Caycedo Marulanda; Husein Moloo; Shiva Jayaraman; Suni Patel; Grégoire Le Gal; Silvana Spadafora; Steven MacLellan; Daniel Trottier; Derek Jonker; Timothy Asmis; Ranjeeta Mallick; Amanda Pecarskie; Tim Ramsay; Marc Carrier
Journal:  BMJ       Date:  2022-09-13

Review 4.  Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.

Authors:  Aikaterini Berdiaki; Monica Neagu; Eirini-Maria Giatagana; Andrey Kuskov; Aristidis M Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Biomolecules       Date:  2021-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.